The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT
Last

(U.S.) $1.04

Today's change-0.02 -1.89%
Updated March 24 3:59 PM -4GMT. Delayed by at least 15 minutes.
 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT
Last

(U.S.) $1.04

Today's change-0.02 -1.89%
Updated March 24 3:59 PM -4GMT. Delayed by at least 15 minutes.

Neptune Technologies & Bioressources Inc crosses below 200-day moving average

Neptune Technologies & Bioressources Inc closed sharply lower Friday, dropping (U.S.)$0.02 or 1.89% to (U.S.)$1.04 and crossing below its 200-day moving average. Over the last five days, shares have gained 2.46% and 7.00% year to date. Shares have underperformed the S&P 500 by 11.13% during the last year.

Key company metrics

  • Open(U.S.) $1.06
  • Previous close(U.S.) $1.06
  • High(U.S.) $1.06
  • Low(U.S.) $1.01
  • Bid / Ask-- / --
  • YTD % change+7.00%
  • Volume31,950
  • Average volume (10-day)68,236
  • Average volume (1-month)97,331
  • Average volume (3-month)204,610
  • 52-week range(U.S.) $0.86 to (U.S.) $1.53
  • Beta-0.02
  • Trailing P/E14.00×
  • P/E 1 year forward34.67×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.10
Updated March 24 3:59 PM -4GMT. Delayed by at least 15 minutes.

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedNov 30, 201611/30/2016Aug 31, 201608/31/2016May 31, 201605/31/2016Feb 29, 201602/29/2016
Revenue12121110
Total other revenue--------
Total revenue12121110
Gross profit3343
Total cost of revenue9987
Total operating expense2141412
Selling / general / administrative53412
Research & development1121
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total-130---8
Operating income10-2-2-2
Interest income (expense), net non-operating---1-10
Gain (loss) on sale of assets--------
Other--------
Income before tax9-2-4-2
Income after tax9-2-40
Income tax, total000-2
Net income11-1-21
Total adjustments to net income--------
Net income before extra. items11-1-21
Minority interest1121
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items11-1-21
Inc. avail. to common incl. extra. items11-1-21
Diluted net income11-1-21
Dilution adjustment--------
Diluted weighted average shares78787877
Diluted EPS excluding extraordinary itemsvalue per share0.14-0.02-0.030.01
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.14-0.02-0.030.01